Dr. Mark D Pagel, Professor of Cancer System Imaging, at MD Anderson Cancer Center, University of Texas and Dr. Mrignayani Kotecha, President of O2M Technologies cordially extend the invitation to submit a manuscript for consideration for a special issue about “EPR Imaging and Applications to Biomedical Science” for the journal Molecular Imaging and Biology (MIB).
About the journal:
The journal of Molecular Imaging and Biology (MIB) 2023 will feature a special issue about “EPR Imaging and Applications to Biomedical Science.” MIB is the premiere journal for molecular imaging research, and the flagship journal for the World Molecular Imaging Society, the European Society for Molecular Imaging, and the Federation of Asian Societies of Molecular Imaging. A special issue of MIB will be an exceptional avenue to highlight advancements in EPR imaging within the international molecular imaging research, focusing on biological and biomedical applications, clinical translation, and chemistry of new agents for EPR imaging.
The deadline for manuscript submissions has been extended to April 30, 2023. We will follow the standard procedure for on-line manuscript submission through the MIB web site, the external review process, and acceptance steps for publication. Standard charges for publication in MIB will apply to this special issue. See more details here.
The deadline for submitting manuscripts for consideration in the hardcopy issue is April 30, 2023. The special issue is scheduled to be published in hardcopy format in December 2023. The publications will also be available as an electronic Special Collection on the publisher’s web site. Notably, there will also be an on-line collection of publications from this hardcopy issue, as well as additional electronic-only publications that are submitted later. For this reason, the electronic, on-line collection has a submission deadline listed as “ongoing” on the Collections web page.
If you have questions or suggestions, please reach out to Dr. Pagel (firstname.lastname@example.org) or Dr. Kotecha (email@example.com).